Sharda Cropchem Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹1,289Cr
- +38.8% YoY
- +38.8% QoQ
- Net profit
- ₹145Cr
- +367.7% YoY
- +95.9% QoQ
- Margin
- 19%
- +7 pp YoY
- +5 pp QoQ
Guidance rank: #7 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Expected volume growth of around 15% in FY '27. The company expects volume growth of around 15% for FY '27.
From Sharda Cropchem Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Expected volume growth of around 15% in FY '27.
- Revenue growth anticipated between 15% to 20% in FY '27.
- Q4 FY '26 projected as the strongest quarter with demand growth continuing.
- Growth driven by both new dealers and expanded geographic reach, especially in Europe.
- Price levels expected to improve gradually, supporting better margins.
- Strong pipeline with 1,076 product registrations in approval, supporting sustained future growth.
2 more points from Sharda Cropchem Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Sharda Cropchem Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Planned capital expenditure (capex) for FY '26 is around INR 500 crores, with INR 399 crores already spent in the first 9 months.
- Capex is aimed at supporting a strong project pipeline, focusing on growth and resilience.
- For FY '27, capex guidance is estimated to be in the range of INR 450 crores to INR 500 crores, though it could be higher due to uncertainties.
- The capex primarily supports increasing the global registration pipeline of approximately 1,070 products.
2 more points from Sharda Cropchem Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sharda Cropchem Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- As of December 31, 2025, Sharda Cropchem's total product registrations stand at 3,004 globally.
- There are 1,076 product registration applications currently in the approval pipeline.
- Regional breakup of pending registrations: Europe - 698, NAFTA - 100, LATAM - 153, Rest of the World - 125.
- Registration process timelines are uncertain; can range from 1-2 years to even 6-7 years due to regulatory complexities.
2 more points from Sharda Cropchem Ltd's call on order book
Create a free account to keep reading this call
Sharda Cropchem Ltd — Quarterly revenue & net profit
Sharda Cropchem Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,289 | 929 | +38.8% | 929 | +38.8% |
| Operating profit (EBITDA) | 241 | 115 | +109.6% | 133 | +81.2% |
| Operating margin | 19% | 12% | +7 pp | 14% | +5 pp |
| Profit before tax | 179 | 46 | +289.1% | 86 | +108.1% |
| Net profit (PAT) | 145 | 31 | +367.7% | 74 | +95.9% |
| EPS (₹) | 16.09 | 3.45 | +366.4% | 8.24 | +95.3% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.1K Cr, net profit ₹92 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sharda Cropchem's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Bhagiradha Chemicals & Industries (Q3 FY26)
114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran
- Advance Agrolife (Q3 FY26)
Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways
- Khaitan Chemical (Q3 FY26)
Q3-FY26 operational revenue: INR 2,657 million, up 34% year-on-year (Page 23, 24). Key investor presentation takeaways from Khaitan Chemical's Q3 FY26 investor
- Rama Phosphates (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹23,800 lakhs, up 33% YoY (Q3 FY25: ₹17,962 lakhs) [Page 9] . Key investor presentation takeaways from Rama Phosphates's Q3 FY2
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Insecticides IndiaGood growth2
- Anya Polytech &Good growth1
- Madhya Bharat Agro ProductsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sharda Cropchem Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sharda Cropchem Ltd Q3 FY26 results?
Expected volume growth of around 15% in FY '27. The company expects volume growth of around 15% for FY '27.
What is Sharda Cropchem Ltd share price analysis?
Sharda Cropchem Ltd currently shows a neutral. The stock trades at a P/E of 11.3 with a market cap of ₹7,095 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sharda Cropchem Ltd planning capital expenditure?
Planned capital expenditure (capex) for FY '26 is around INR 500 crores, with INR 399 crores already spent in the first 9 months.
Keep Sharda Cropchem Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
